Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cross Country Healthcare (CCRN) Intangibles: 2010-2025

Historic Intangibles for Cross Country Healthcare (CCRN) over the last 16 years, with Q3 2025 value amounting to $35.5 million.

  • Cross Country Healthcare's Intangibles fell 2352.92% to $35.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $35.5 million, marking a year-over-year decrease of 2352.92%. This contributed to the annual value of $42.2 million for FY2024, which is 2254.9% down from last year.
  • Latest data reveals that Cross Country Healthcare reported Intangibles of $35.5 million as of Q3 2025, which was down 2352.92% from $37.7 million recorded in Q2 2025.
  • Cross Country Healthcare's Intangibles' 5-year high stood at $63.1 million during Q1 2023, with a 5-year trough of $31.8 million in Q2 2021.
  • Its 5-year average for Intangibles is $45.5 million, with a median of $44.1 million in 2021.
  • Its Intangibles has fluctuated over the past 5 years, first soared by 5560.27% in 2023, then plummeted by 2352.92% in 2025.
  • Cross Country Healthcare's Intangibles (Quarter) stood at $48.2 million in 2021, then fell by 7.3% to $44.7 million in 2022, then grew by 21.79% to $54.5 million in 2023, then dropped by 22.55% to $42.2 million in 2024, then dropped by 15.79% to $35.5 million in 2025.
  • Its Intangibles stands at $35.5 million for Q3 2025, versus $37.7 million for Q2 2025 and $40.0 million for Q1 2025.